<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
<head>
<title>Kompetenznetz KJP TDM e.V.</title>
<meta http-equiv="Content-type" content="text/html; charset=utf-8" />

<!-- add your meta tags here -->
<meta name="description" content="TDM, KJP, Therapeuthical, Drug, Monitoring, Kinderpsychatrie, Jugendpsychatrie, Forschungsdatenbank, Internetbasiert, Entwicklungspsychopharmakologie, Arzneimittelserumspiegel, Blutspiegel, Serumkonzentration, Multizentrisches Forschungsprojekt, Serumspiegel, Plasmaspiegel" />
<meta name="keywords" content="TDM, KJP, Therapeuthical, Drug, Monitoring, Kinderpsychatrie, Jugendpsychatrie, Forschungsdatenbank, Internetbasiert, Entwicklungspsychopharmakologie, Arzneimittelserumspiegel, Blutspiegel, Serumkonzentration, Multizentrisches Forschungsprojekt, Serumspiegel, Plasmaspiegel" />

<link href="css/my_layout.css" rel="stylesheet" type="text/css" />
<!--[if lte IE 7]>
<link href="css/patches/patch_my_layout.css" rel="stylesheet" type="text/css" />
<![endif]-->
</head>
<body>
  <div id="page_margins">
    <div id="border-top">
      <div id="edge-tl"></div>
      <div id="edge-tr"></div>
    </div>
    <div id="page">
      <div id="header">
        <div id="topnav">
          <!-- start: skip link navigation -->
          <a class="skip" title="skip link" href="#navigation">Skip to the navigation</a><span class="hideme">.</span>
          <a class="skip" title="skip link" href="#content">Skip to the content</a><span class="hideme">.</span>
          <!-- end: skip link navigation --><a href="#"><img src="images/english.gif" /></a>&nbsp;<a href="http://www.tdm-kjp.de/publikationen.html"><img src="../images/german.gif" /></a><br /><a href="contact.html">Contact</a> | <a href="contact.html">Imprint</a>
        </div>
        <img src="images/logo.jpg" />
      </div>
      <div id="nav">
        <!-- skiplink anchor: navigation -->
        <a id="navigation" name="navigation"></a>
        <div id="nav_main">
          <!-- main navigation: #nav_main -->
          <ul>
           <li><a href="index.html">News &amp; Aims</a></li>
            <li><a href="introduction.html">Introduction</a></li>
            <li><a href="database.html">Database</a></li>
            <li><a href="labor.html">TDM-laboratory</a></li>
            <li><a href="participants.html">Participants</a></li>
            <li><a href="projects.html">Projects</a></li>
            <li id="current"><a href="#">Publications &amp; Support</a></li>
            <li><a href="contact.html">Contact</a></li>
          </ul>
        </div>
      </div>
      <div id="main">
        <div id="col1">
          <div id="col1_content" class="clearfix">
            <!-- add your content here -->
            <h2>Contact</h2>
            <h3>Secretary office:</h3>
            <p><b>Competence network &quot;TDM KJP e.V.&quot;</b><br />
Andrea B&auml;uerle<br />
Clinic for child and youth psychiatry/ psychotherapy University of Ulm<<br />
Steinh&ouml;velstr. 5<br />
89075 Ulm<br /><br /><br />

Tel.:	(+49) 0731-500-61710<br />
Email:	<a href="mailto:andrea.baeuerle@uniklinik-ulm.de" target="_blank">andrea.baeuerle@uniklinik-ulm.de</a>
</p></div>
        </div>
        <div id="col3">
          <div id="col3_content" class="clearfix">
            <!-- add your content here -->
            <div id="teaser2">

            </div>
            <h1>Financial Support</h1>
            <div class="c75l"><p>The German Ministry for Education and Science (Bundesministerium f&uuml;r Bildung und Forschung <a href="http://www.bmbf.de" target="_blank">BMBF</a>) financially supports the Competence Network TDM KJP within its programme for the development of new instruments and methods for patient-oriented medical research.<br />
            Title of the project: &quot;Therapeutic Drug Monitoring in child and adolescent psychiatry. Competence network and patient registry for psychopharmacological research: establishment and further development of a multicentre IT-infrastructure.&quot;</p></div>
            <div class="c25r"><a href="http://www.bmbf.de" target="_blank"><img src="../images/BMBF_Logo_DEU.jpg" title="Bundesministerium f&uuml;r Bildung und Forschung" alt="Bundesministerium f&uuml;r Bildung und Forschung" /></a></div>
            <div style="clear:both"></div>
            <p>Society for &quot;Durchf&uuml;hrung Neurowissenschaftlicher Tagungen e.V.&quot;, Paulsborner-Strasse 44, 14193 Berlin
            </p><br /><br />
            <h1>Publications</h1>
            			<p>Baumann P, Hiemke C, Ulrich S, Eckermann G, Gaertner I, Gerlach M, Kuss HJ, Laux G, M&uuml;ller-Oerlinghausen B, Rao ML, Riederer P, Zernig G (2004):<br />
<b>The AGNP-TDM expert group consensus guidelines: Therapeutic drug monitoring in Psychiatry.</b><br />
Pharmacopsychiatry 2004; 37:243-265.
</p>
 

<p>Fleischhaker C, Heiser P, Hennighausen K et al (2006):<br />
<b>Clinical drug monitoring in child and adolescent psychiatry: side effects of atypical neuroleptics.</b><br />
J Child Adolesc Psychopharmacol 2006; 16:308-316.</p>

<p>Fleischhaker C, Heiser P, Hennighausen K et al (2007):<br />
<b>Weight gain associated with clozapine, olanzapine and risperidone in children and adolescents.</b><br />
J Neural Transm 2007; 114:273-280.
</p>

<p>Fleischhaker C, Heiser P, Hennighausen K et al (2008):<br />
<b>Weight gain in children and adolescents during 45 weeks treatment with clozapine, olanzapine and risperidone.</b><br />
J Neural Transm DOI: 10.1007/s00702-008-0105-9.
</p>

<p>Gerlach M, H&uuml;nnerkopf R, Rothenh&ouml;fer S, Libal G, Burger R, Clement H-W, Fegert JM, Wewetzer Ch, Mehler-Wex C:<br />
<b>Therapeutic drug monitoring of quetiapine in adolescents with psychotic disorders.</b><br />
Pharmacopsychiatry 2007; 40:72-76.
</p>
 
<p>Gerlach M, Klampfl K, Mehler-Wex C, Warnke A (2009):<br />
<b>Besonderheiten der Therapie mit Neuro-Psychopharmaka im Kindes- und Jugendalter.</b><br />
In: Gerlach M, Mehler-Wex C, Walitza S, Warnke A, Wewetzer C (Hrsg.). Neuropsychopharmaka im Kindes- und Jugendalter. Grundlagen und Therapie.<br />
2. Auflage. Wien, New York: Springer, 2009; 73-89.
</p>
 
<p>Gerlach M, Klampfl K, Warnke A, Mehler-Wex C (2010):<br />
<b>Besonderheiten der Therapie mit Neuro-Psychopharmaka im Kindes- und Jugendalter, Psychopharmakotherapie</b><br />
Arzneimitteltherapie psychischer und neurologischer Erkrankungen, 17. Jahrgang, Nr. 3, 2010; 118-125.
</p>

<p>Gerlach M, Rothenh&ouml;fer S, Mehler-Wex C, Baumann P, Hiemke Ch, Eckermann G, G&auml;rtner I, Kuss HJ, Laux G, M&uuml;ller-Oerlinghausen B, Rao ML, Riederer P, Ulrich S, Zernig G, Wewetzer Ch (2005):<br />
<b>Therapeutisches Drug Monitoring in der Kinder- und Jugendpsychiatrie.</b><br />
Psychopharmakotherapie 2005; 4:118-120.
</p>

<p>Gerlach M, Rothenh&ouml;fer S, Mehler-Wex C, Fegert JM, Schulz E, Wewetzer Ch, Warnke A (2006):<br />
<b>Therapeutisches Drug-Monitoring in der Kinder- und Jugendpsychiatrie - Grundlagen und praktische Empfehlungen.</b><br />
Z Kinder-Jugendpsychiatr 2006; 34: 5-13.
</p>

<p>Kirchheiner J, Brockmoller J (2005):<br />
<b>Clinical consequences of cytochrome P450 2C9 polymorphisms.</b><br />
Clin Pharmacol Ther 2005; 77(1): 1-16.
</p>

<p>Kirchheiner J, Br&oslash;sen K, Dahl ML, Gram LF, Kasper S, Roots I, Sjoqvist F, Spina E, Brockm&ouml;ller J (2001):<br />
<b>CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages.</b><br />
Acta Psychiatr Scand 2001; 104(3): 173-192.
</p>

<p>Klampfl K, Mehler-Wex C, Warnke A, Gerlach M (2010):<br />
<b>Therapeutisches Drug-Monitoring in der Kinder- und Jugendpsychiatrie. Psychopharmakotherapie. Psychopharmakotherapie, Arzneimitteltherapie psychischer und neurologischer Erkrankungen, 17. Jahrgang, Nr. 4, 2010; 188 - 192.</b>
</p>

<p>Klampfl K, Taurines R, Preuss A, Burger R, Rothenh&ouml;fer S, Wewetzer C, Pfuhlmann B, Fegert J, Gerlach M, Mehler-Wex C (2010):<br />
<b>Serum Concentrations, Therapeutic Response and Side Effects in Children and Adolescents with Impulsive- Aggressive Symptoms during Risperidone Therapy.</b><br />
Pharmacopsychiatry 2010; 43(2):58-65.
</p>
           </div>
         </div>
          <!-- IE Column Clearing -->
          <div id="ie_clearing"> &#160; </div>
        </div>

      <!-- begin: #footer -->
      <div id="footer">Erstellt von <a href="http://www.3rat.de" target="_blank">3rat</a>
      </div>
   </div>
    <div id="border-bottom">
      <div id="edge-bl"></div>
      <div id="edge-br"></div>
    </div>
  </div>
</body>
</html>
